TNNT2 and left ventricular hypertrophy: hs-cTnT, a specific and sensitive biomarker of myocardial injury, strongly correlates with the presence of subclinical CHD or other cardiac structural and functional abnormalities such as AF, left ventricular hypertrophy, and heart failure, all of which lead to adverse cardiovascular outcomes.32